Evaluation of CRP SNV rs2808630 and acute proinflammatory biomarkers in patients with CKD and PLHIV with CKD: a case-control study
Andrea Torres-Rojas(Universidad de Guadalajara), Monserrat Álvarez-Zavala(Universidad de Guadalajara), Zyanya Reyes-Castillo(Universidad de Guadalajara), Adriana Valle-Rodríguez(Hospital Civil de Guadalajara), Pedro Martínez-Ayala(Hospital Civil de Guadalajara), Jaime Andrade‐Villanueva(Hospital Civil de Guadalajara), Jorge Hernández‐Bello(Universidad de Guadalajara), Karina Sánchez-Reyes(Universidad de Guadalajara), Jonathan S. Chávez-Íñiguez(Hospital Civil de Guadalajara), Luz Alicia González-Hernández(Universidad de Guadalajara), Vida Verónica Ruíz-Herrera(Hospital Civil de Guadalajara), Jorge Fernando Topete-Reyes(Mexican Social Security Institute)
Cited by 0
Related Papers
Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial
|The Lancet Respiratory Medicine|2021|225
Efficacy and safety of once daily elvitegravir versus twice daily raltegravir in treatment-experienced patients with HIV-1 receiving a ritonavir-boosted protease inhibitor: randomised, double-blind, phase 3, non-inferiority study
|The Lancet Infectious Diseases|2011|172
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
|Science Translational Medicine|2017|169
The PI3K/Akt/mTOR pathway: A potential pharmacological target in COVID-19
|Drug Discovery Today|2021|119
Oral Manifestations Associated with HIV/AIDS Patients
|Medicina|2022|97